...
首页> 外文期刊>Journal of pharmacokinetics and pharmacodynamics >Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves.
【24h】

Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves.

机译:独立模型诊断程序可从完整的药代动力学数据库中对异常值进行先验识别和解释:对应分析,马氏距离和安德鲁斯曲线。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Population pharmacokinetic (PK) (or pharmacodynamic (PD)) modelling aims to analyse the variability of drug kinetics (or dynamics) between numerous subjects belonging to a population. Such variability includes inter- and intra-individual sources leading to important differences between the variation ranges, the relative concentrations and the global shapes of PK profiles. These various sources of variability suggest that the distance metrics between the subjects can be examined under different aspects. Some subjects are so distant from the majority that they tend to be atypical or outliers. This paper presents three multivariate statistical methods to diagnose the outliers within a full population PK dataset, prior to any modelling step. Each method combined all the concentration-time variables to analyse the differences between patients by referring to a distance criterion: (a) Correspondence analysis (CA) used the chi-square distance to highlight the most atypical profiles in terms of relative concentrations; (b) Mahalanobis distance was calculated to extract PK profiles showing atypical shapes due to atypical variations in concentration; (c) Andrews method combined all the concentration variables into a Fourier transformation to give sine-cosine curves showing the clustering behaviours of subjects under the Euclidean distance criterion. After identification of outlier subjects, these methods can also be used to extract the concentration values which cause the atypical states of the patients. Therefore, the outliers will incorporate different variability sources of the PK dataset according to each method and independently of any PK modelling. Finally, a significant positive trend was found between the number of times outlier concentrations were detected (by one, two or three diagnostics) and the NPDE metrics of these concentrations (after a PK modelling): NPDE were highest when the corresponding concentration was detected by more diagnostics a priori. The application of a priori outlier diagnosticsis illustrated here on two PK datasets: stimulated cortisol by synacthen and capecitabine administrated orally.
机译:人群药代动力学(PK)(或药效动力学(PD))建模旨在分析属于人群的众多受试者之间药物动力学(或动力学)的变异性。这种变化包括个体间和个体内来源,导致变异范围,相对浓度和PK曲线的整体形状之间存在重要差异。这些各种可变性来源表明,可以在不同方面检查对象之间的距离度量。一些主题与大多数主题相距甚远,以至于它们往往是非典型或离群的。本文提出了三种多元统计方法,可以在进行任何建模步骤之前,在完整的人口PK数据集中诊断异常值。每种方法都结合了所有浓度-时间变量,通过参照距离标准来分析患者之间的差异:(a)对应分析(CA)使用卡方距离来突出相对浓度方面的最典型特征; (b)计算马氏距离以提取由于浓度的非典型变化而显示非典型形状的PK曲线; (c)安德鲁斯方法将所有浓度变量组合到一个傅立叶变换中,得出正弦-余弦曲线,表明在欧几里德距离准则下对象的聚类行为。在识别出异常对象之后,这些方法也可以用于提取引起患者非典型状态的浓度值。因此,异常值将根据每种方法并独立于任何PK建模并入PK数据集的不同变异性源。最后,在检测到异常值的次数(通过一,两个或三个诊断)与这些浓度的NPDE度量值之间(在PK模型之后)发现了显着的正趋势:当通过检测到相应的浓度时,NPDE最高。先验更多诊断。先验异常诊断在两个PK数据集上的应用:Synacthen刺激的皮质醇和口服卡培他滨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号